Traws Pharma, Inc. — Director's Dealing 2015

Apr 20, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Onconova Therapeutics, Inc. (ONTX)
CIK: 0001130598
Period of Report: 2015-04-16

Reporting Person: Guerin Mark Patrick (Chief Accounting Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-04-16	Stock Option (right ot purchase)	$2.32	A	15000	Acquired	2025-04-16	Common Stock (15000)	Direct

Footnotes

F1: These options vest over four years in 48 equal monthly installments.